The main objective of the trial is to assess the efficacy and safety of the drug trimodulin as adjunctive treatment to standard of care compared to placebo plus standard of care in adults hospitalized with severe community-acquired pneumonia on invasive mechanical ventilation.
Contact phoneSparrow Clinical Research Institute | 517. 364. 5760
Principal investigatorDr. Jennifer R. Ely, DO